Pfizer

home.pfizer.com · New York City, United States of America

Pfizer is a global biopharmaceutical company that discovers, develops, manufactures, and markets prescription medicines and vaccines for a wide range of therapeutic areas including oncology, immunology, cardiology, and infectious diseases. It serves patients, healthcare providers, governments, and health systems worldwide, generating revenue primarily through the sale of patented and off-patent drugs and vaccines. The company also engages in research collaborations and licensing agreements with other biopharma and biotech firms.

Revenue
$1B+
Employees
5,001+
Founded
1849
Headquarters
New York City, United States of America

Pfizer customers on Arbolus

Total customers 11 10 current · 1 former
Reviews growth 5 new reviews since May 2026

Customers who reviewed Pfizer

Seniority of Pfizer customers

The largest group of people who reviewed Pfizer holds Manager roles (50%), followed by C-Suite (40%) and Director (10%).

  • Manager 50%
  • C-Suite 40%
  • Director 10%

Customers sample

Revenue Partner Not specified NPS 8 Not renewing
Revenue Partner Manager NPS 6 Undecided
Revenue Partner C-Suite NPS 8

Employer names and spend open in the full report, along with the other 8 customers.

What 11 Arbolus experts think of Pfizer

Overall sentiment: Positive

NPS feedback is predominantly positive, with the majority of scores ranging between 6 and 10, primarily driven by executive and clinical Users citing scale, R&D strength, and distribution reliability as key value drivers. Renewal intent among Influencers is generally favorable, though select Influencers report offboarding or uncertain renewal, often tied to pricing and market competition. Most experts are in the advanced implementation or pilot stages, reflecting ongoing institutional engagements and product evaluations. Main qualitative themes include recognition of Pfizer's large-scale infrastructure, scientific leadership, product availability, and concerns over complexity and cost.

Everything 11 customers told us about Pfizer.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

9 Net Promoter Score, from 11 scored reviews
  • Promoters 3
  • Passives 6
  • Detractors 2

Praised

  • Global Scale and Reach
  • Supply-Chain Reliability
  • R&D Investment and Innovation
  • Digital Patient Support

Criticised

  • Portfolio and Patent-Expiration Risk
  • Competitive Therapy Threats
  • Pricing and Market Access Pressure
  • Internal Complexity

What Pfizer customers say

Global Scale and Reach

“Pfizer's ability to reach a wide patient audience and deliver medicines worldwide is unmatched, making it a reliable partner for healthcare organizations needing broad supply.”

Revenue Partner

Supply-Chain Reliability

“I trust Pfizer due to its large-scale manufacturing and global distribution network, which ensures strong product availability across regions.”

Revenue Partner

R&D Investment and Innovation

“I value Pfizer for its deep commitment to research and development, with extensive investments supporting a robust therapy pipeline beyond its current commercial portfolio.”

Revenue Partner

Renewal intent

Plan to renew 50%
  • Will renew 2
  • Undecided 1
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 100% 2 answers
  • Manager 0% 1 answer
  • Not specified 0% 1 answer
  • 8/10 Average score from customers who will renew
  • 6/10 Average score from undecided customers
  • 8/10 Average score from customers not renewing

Report

Oct 2026 11 + 0

For people who use Pfizer

Do you use Pfizer at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 11 customers of Pfizer have already contributed

Takes a few minutes. Your identity stays anonymous.